125 related articles for article (PubMed ID: 7712120)
1. No major role for the dopamine D2 receptor Ser-->Cys311 mutation in schizophrenia.
Laurent C; Bodeau-Péan S; Campion D; d'Amato T; Jay M; Dollfus S; Thibault F; Petit M; Samolyk D; Martinez M
Psychiatr Genet; 1994; 4(4):229-30. PubMed ID: 7712120
[TBL] [Abstract][Full Text] [Related]
2. Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia.
Tanaka T; Igarashi S; Onodera O; Tanaka H; Fukushima N; Takahashi M; Kameda K; Tsuji S; Ihda S
Am J Med Genet; 1996 Apr; 67(2):208-11. PubMed ID: 8723049
[TBL] [Abstract][Full Text] [Related]
3. Dopamine DRD2/Cys311 is not associated with chronic schizophrenia.
Crawford F; Hoyne J; Cai X; Osborne A; Poston D; Zaglul J; Dajani N; Walsh S; Bradley R; Solomon R; Mullan M
Am J Med Genet; 1996 Sep; 67(5):483-4. PubMed ID: 8886166
[TBL] [Abstract][Full Text] [Related]
4. No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients.
Chen CH; Chien SH; Hwu HG
Am J Med Genet; 1996 Jul; 67(4):418-20. PubMed ID: 8837714
[TBL] [Abstract][Full Text] [Related]
5. A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys).
Itokawa M; Arinami T; Futamura N; Hamaguchi H; Toru M
Biochem Biophys Res Commun; 1993 Nov; 196(3):1369-75. PubMed ID: 7902708
[TBL] [Abstract][Full Text] [Related]
6. No association of the Ser/Cys311 DRD2 molecular variant with schizophrenia using a classical case control study and the haplotype relative risk.
Verga M; Macciardi F; Pedrini S; Cohen S; Smeraldi E
Schizophr Res; 1997 May; 25(2):117-21. PubMed ID: 9187010
[TBL] [Abstract][Full Text] [Related]
7. No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis.
Sasaki T; Macciardi FM; Badri F; Verga M; Meltzer HY; Lieberman J; Howard A; Bean G; Joffe RT; Hudson CJ; Kennedy JL
Am J Med Genet; 1996 Jul; 67(4):415-7. PubMed ID: 8837713
[TBL] [Abstract][Full Text] [Related]
8. An association study between the Cys311 variant of dopamine D2 receptor gene and schizophrenia in the Okinawan population.
Kaneshima M; Higa T; Nakamoto H; Nagamine M
Psychiatry Clin Neurosci; 1997 Dec; 51(6):379-81. PubMed ID: 9472122
[TBL] [Abstract][Full Text] [Related]
9. Association of structural polymorphism of the dopamine D2 receptor gene and alcoholism.
Higuchi S; Muramatsu T; Murayama M; Hayashida M
Biochem Biophys Res Commun; 1994 Nov; 204(3):1199-205. PubMed ID: 7980596
[TBL] [Abstract][Full Text] [Related]
10. DRD2 Ser311/Cys311 polymorphism in schizophrenia.
Shaikh S; Collier D; Arranz M; Ball D; Gill M; Kerwin R
Lancet; 1994 Apr; 343(8904):1045-6. PubMed ID: 7909081
[No Abstract] [Full Text] [Related]
11. DRD2 Ser311/Cys311 polymorphism in schizophrenia.
Asherson P; Williams N; Roberts E; McGuffin M; Owen M
Lancet; 1994 Apr; 343(8904):1045. PubMed ID: 7909080
[No Abstract] [Full Text] [Related]
12. Ser-311-Cys polymorphism of the dopamine D2 receptor gene and schizophrenia--an analysis of schizophrenic patients in Fukuoka.
Harano M
Kurume Med J; 1997; 44(3):201-8. PubMed ID: 9339651
[TBL] [Abstract][Full Text] [Related]
13. Association of dopamine D2 receptor molecular variant with schizophrenia.
Arinami T; Itokawa M; Enguchi H; Tagaya H; Yano S; Shimizu H; Hamaguchi H; Toru M
Lancet; 1994 Mar; 343(8899):703-4. PubMed ID: 7907680
[TBL] [Abstract][Full Text] [Related]
14. DRD2 Ser311/Cys311 polymorphism in schizophrenia.
Nanko S; Hattori M; Dai XY; Fukuda R; Kazamatsuri H
Lancet; 1994 Apr; 343(8904):1044. PubMed ID: 7909078
[No Abstract] [Full Text] [Related]
15. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms.
Spurlock G; Williams J; McGuffin P; Aschauer HN; Lenzinger E; Fuchs K; Sieghart WC; Meszaros K; Fathi N; Laurent C; Mallet J; Macciardi F; Pedrini S; Gill M; Hawi Z; Gibson S; Jazin EE; Yang HT; Adolfsson R; Pato CN; Dourado AM; Owen MJ
Am J Med Genet; 1998 Feb; 81(1):24-8. PubMed ID: 9514583
[TBL] [Abstract][Full Text] [Related]
16. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms.
Himei A; Koh J; Sakai J; Inada Y; Akabame K; Yoneda H
Psychiatry Clin Neurosci; 2002 Feb; 56(1):97-102. PubMed ID: 11929577
[TBL] [Abstract][Full Text] [Related]
17. Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: Ser311Cys polymorphisms of the dopamine D2-receptor gene and schizophrenia.
Itokawa M; Arinami T; Toru M
J Pharmacol Sci; 2010; 114(1):1-5. PubMed ID: 20716857
[TBL] [Abstract][Full Text] [Related]
18. Dopamine receptor D2 Ser/Cys311 variant associated with disorganized symptomatology of schizophrenia.
Serretti A; Macciardi F; Smeraldi E
Schizophr Res; 1998 Nov; 34(3):207-10. PubMed ID: 9850987
[TBL] [Abstract][Full Text] [Related]
19. Association study of bipolar disorder using a functional polymorphism (Ser311-->Cys) in the dopamine D2 receptor gene.
Craddock N; Roberts Q; Williams N; McGuffin P; Owen MJ
Psychiatr Genet; 1995; 5(2):63-5. PubMed ID: 7551964
[TBL] [Abstract][Full Text] [Related]
20. DRD2 Ser311/Cys311 polymorphism in schizophrenia.
Pal H; Saxena S
Natl Med J India; 1995; 8(3):125-6. PubMed ID: 7780354
[No Abstract] [Full Text] [Related]
[Next] [New Search]
